Loading
Total declarations
Company
▲ Purchases (21 ops.)
▼ Sales (0 ops.)
Latest filing published 25 Nov 2024 for Greenwich LifeSciences, Inc., €12k. Read the official filing
Filing timeline
BuySaleJaye Thompson
Insider track record
Disclosed buys
21
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-31.3%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Jaye Thompson: trading record in brief
All filings by Jaye Thompson on record concern Greenwich LifeSciences, Inc. In total, 21 filings cover trades dated from 13 January 2022 to 21 November 2024.
Every open-market trade on record is a purchase: 21 purchases worth €151k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. So far in 2024, the count stands at 4 purchases and no sales.
Half of the purchases are above €4,944 and half below. 16 out of 20 purchases came within 30 days of a purchase by at least one other insider of the same company. Purchases made close together by different insiders form what is called a cluster.
The newest entry dates from 25 November 2024: an open-market purchase of €12k, in Greenwich LifeSciences, Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Jaye Thompson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations20 total
1,000 shares@ US$12.917.0% of flowCommon StockSEC:0001493152-24-047527:0
Canonical exit: 19 Feb 2025 (T+90)
800 shares@ US$13.855.8% of flowCommon StockSEC:0001493152-24-036275:0
Canonical exit: 10 Nov 2024 (T+90)
1,000 shares@ US$15.158.0% of flowCommon StockSEC:0001493152-24-030163:0
Canonical exit: 31 Oct 2024 (T+90)
1,000 shares@ US$16.008.4% of flowCommon StockSEC:0001493152-24-028606:0
Canonical exit: 16 Oct 2024 (T+90)
500 shares@ US$8.572.3% of flowCommon StockSEC:0001493152-23-038777:0
Canonical exit: 25 Jan 2024 (T+90)
600 shares@ US$8.714.1% of flowCommon StockSEC:0001493152-23-034479:0
Canonical exit: 25 Dec 2023 (T+90)
250 shares@ US$9.491.2% of flowCommon StockSEC:0001493152-23-024661:0
Canonical exit: 11 Oct 2023 (T+90)
250 shares@ US$11.221.5% of flowCommon StockSEC:0001493152-23-015096:0
Canonical exit: 27 Jul 2023 (T+90)
1,000 shares@ US$11.876.2% of flowCommon StockSEC:0001493152-23-011921:0
Canonical exit: 10 Jul 2023 (T+90)
250 shares@ US$12.711.7% of flowCommon StockSEC:0001493152-23-007822:0
Canonical exit: 13 Jun 2023 (T+90)
250 shares@ US$15.3952.1% of flowCommon StockSEC:0001493152-23-006138:0
Canonical exit: 25 May 2023 (T+90)
250 shares@ US$20.842.7% of flowCommon StockSEC:0001493152-23-003766:0
Canonical exit: 4 May 2023 (T+90)
250 shares@ US$19.202.5% of flowCommon StockSEC:0001493152-23-002849:0
Canonical exit: 27 Apr 2023 (T+90)
250 shares@ US$16.502.2% of flowCommon StockSEC:0001493152-23-001506:0
Canonical exit: 13 Apr 2023 (T+90)
250 shares@ US$12.941.7% of flowCommon StockSEC:0001493152-22-035936:0
Canonical exit: 16 Mar 2023 (T+90)
250 shares@ US$13.981.9% of flowCommon StockSEC:0001493152-22-034537:0
Canonical exit: 2 Mar 2023 (T+90)
500 shares@ US$16.745.4% of flowCommon StockSEC:0001493152-22-010484:0
Canonical exit: 18 Jul 2022 (T+90)
500 shares@ US$18.475.8% of flowCommon StockSEC:0001493152-22-002817:0
Canonical exit: 1 May 2022 (T+90)
500 shares@ US$16.335.1% of flowCommon StockSEC:0001493152-22-002021:0
Canonical exit: 21 Apr 2022 (T+90)
1,000 shares@ US$19.9912.3% of flowCommon StockSEC:0001493152-22-001189:0
Canonical exit: 13 Apr 2022 (T+90)
20 of 20 declarations
